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Abstract
Background: Beliefs about substance use disorder (SUD) shape how patients, treatment professionals and the
general public view addiction and its treatment. A U.S. developed scale exists to assess such beliefs, but it has never
been tested in Norway nor normed on any general population sample.
Methods: The Short Understanding of Substance Abuse Scale (SUSS) was translated from English to Norwegian and
used to assess beliefs about the nature of addiction among addiction treatment professionals (N = 291), patients with
SUDs (N = 133) and respondents from the general public (N = 216). The disease and psychosocial model subscales of
the SUSS were examined with a multigroup factor analysis to confirm that the constructs were invariant across the
studied groups. We also controlled for demographic covariates in a multiple indicator multiple cause model.
Results: The multigroup confirmatory factor analysis of the SUSS yielded a partial scalar invariant model and thus, we
were able to compare latent means between groups. In unadjusted comparisons, patients and the general public
reported significantly higher endorsement of disease model beliefs than did professionals. However, the difference
between professionals and the general public disappeared when the comparison was adjusted for covariates (i.e., age,
gender, education). In both unadjusted and adjusted analyses, the general public group but not the patient group
scored significantly lower than professionals on the psychosocial belief scale.
Conclusion: The SUSS is useable with slight adaptations in Norwegian samples. Norwegian treatment professionals
have different views of substance use disorder than do patients and the general public. This may create opportunities
for dialogue and mutual learning, but also presents risk of miscommunication and distrust.
Keywords: Substance-related disorders, Attitudes of health personnel, Professional-patient relations, Patient-centered
care, Health services research, Alcoholics anonymous
Background
How treatment providers and treatment seekers
conceptualize substance use disorders (SUD) has many
practical implications [1–3], including for example
whether persons with addiction are blamed for their
SUD [4]. Different understandings of etiology may influ-
ence clinicians’ choice of treatment strategies (e.g.,
behavioral self-control training versus 12-step facilitation
counseling) and the treatment goals to which the
clinician and patient agree (e.g., abstinence versus con-
trolled use) [5, 6]. Among individuals with a SUD, the
understanding of addiction could potentially influence
whether they seek treatment or try to solve the problem
on their own [7]. The beliefs of the general public,
though rarely studied, are also of interest as they may in-
fluence their willingness to support publically funded
treatment services and to encourage loved ones to access
them. Beliefs about SUD are thus clearly important to
study in health services research, making it valuable to
have reliable instruments that have been validated in
multiple cultural contexts.
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The Short Understanding of Substance Abuse Scale
(SUSS) was developed in the U.S. to measure therapist
and patient beliefs regarding substance dependence [3, 8].
The SUSS is a modification of Moyers and Miller’s
longer alcohol-focused “Understanding of Alcoholism
Scale” [2]. The SUSS assesses beliefs about illicit
drugs as well as alcohol in three domains; disease
model, psychosocial model and eclectic model beliefs.
The disease model comprises beliefs that alcohol and
drug dependence are chronic illnesses that can only
be arrested through life-long abstinence. The disease
model beliefs has its origin in the disease concept of
the 12-step treatment model [4, 9], which in turn was
influenced by the 12-step program of Alcoholics An-
onymous (AA) [10, 11]. The disease model beliefs
have also recently been associated with the “brain dis-
ease” concept of addiction (which AA did not en-
dorse) prominently promoted by NIDA researchers,
with its emphasis on disturbed neurobiology of long-
term duration [12, 13]. The psychosocial model beliefs
reflect the view that substance misuse is a product of
psychological and social factors (e.g., cultural influ-
ences and family environment) [2, 8, 14]. The mean-
ing of the third scale, the eclectic model is less clear,
but items loading on this factor reject the idea that
addiction is a homogeneous entity with a single eti-
ology [2]. Research in both the U.S. and Switzerland
showed that this subscale had mediocre psychometric
properties, leading to the recommendation to use
only the first two scales [2, 15].
In previous studies with the SUSS among profes-
sionals, higher age was associated with greater
endorsement of the disease model beliefs [1]. Higher
educational level was associated with less endorse-
ment of disease model beliefs and higher endorse-
ment of psychosocial model beliefs [1]. A study
conducted in outpatient treatment settings found that
the more a practitioner’s beliefs about dependence
reflect a psychosocial understanding, the more likely
s/he would be to use a cognitive or motivational
treatment approach [6]. Conversely, the more practi-
tioners’ beliefs reflect a disease model understanding
of dependence, the more likely they would be to use
a directive or 12-step treatment approach. Similarly,
there is a negative association between disease model
beliefs and endorsing “moderate drinking” as a treat-
ment goal [5]. Among patients, stronger adherence to
the disease model beliefs was associated with more
involvement in supportive fellowships like the 12-step
groups following treatment [3]. To our knowledge,
the SUSS has not been used to directly compare pro-
fessionals’ beliefs to those of patients or to the gen-
eral public. Neither has it been employed in Norway,
a country where the 12-step disease model has been
less influential than it has in the U.S. where the SUSS
was originally developed [16, 17].
Before applying a scale developed in one culture to an-
other (or indeed in a different subculture within the
same society), one ought to check whether the question-
naire measures the constructs in the same way in the re-
spective cultures. The SUSS was developed in the U.S.,
and had a similar but somewhat different factor struc-
ture in a Swiss German sample; one disease model item
was replaced with an eclectic model item as a result of
their exploratory factor analysis [15]. Thus, one needs to
affirm that the measurement and the structure of the
underlying constructs are invariant (equivalent) across
the studied samples [18, 19]. The equality of meaning of
the items is usually assumed between groups but not
tested; the same is true for the intercepts of the items.
Different understanding and scoring of survey responses
may be due to educational level, cultural background or
experiences of SUD [18]. Non-equivalence can also exist
if different mode of data collection is used [20]. Thus,
one should use statistical approaches to test measure-
ment equivalence. Multigroup confirmatory factor ana-
lysis (MGCFA) is the most widely used method for such
testing [18].
The aim of this study was to test the measurement
equivalence of the SUSS across Norwegian groups (pro-
fessionals, patients and the general public), and then
examine differences between the groups regarding the
understanding of substance dependence.
Methods
Participants and procedures
The addiction treatment professional group (hereafter
referred to as ‘professionals’) participated in a cross-
sectional study in the southern five counties of Health Re-
gion South East, Norway, in 2008. That study aimed to
describe participants’ attitudes towards and referral prac-
tices to Twelve Step mutual help organizations. An
assigned contact person in each treatment center re-
cruited the participants and returned the below described
questionnaire anonymously to the researchers. Returning
the survey was considered as an implied consent. The
response rate was 80 % (291 of 365 eligible respondents).
Most (80 %) worked in in-patient units. The patient
group was enrolled by study staff in a clinical trial at
the in-patient detoxification ward at the Addiction
Unit, Sørlandet Hospital in Kristiansand, Norway from
September 2008 to August 2010. The participants
provided written informed consent before inclusion.
Of 156 eligible patients, 16 refused participation and
seven did not provide answers to any question on the
main instrument (see below), yielding N = 133 for the
analysis (85 % response rate). The participants in both
of these studies filled out the below described paper
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based questionnaire as a part of their respective
study, each of which has been described in detail
elsewhere [16, 17, 21, 22]. The Regional Ethics Com-
mittee of the South-East Health Region, Norway, ap-
proved both studies. No incentives were offered to
participants. The Addiction Unit at the Sørlandet
Hospital granted permission to use the data from
these previous studies. The general population sample
(N = 216) was recruited via Facebook, with a link to
an online survey posted on several Facebook groups
or spread via Facebook contacts of the first author.
The data collection was carried out from October 15
to October 20, in 2014. The inclusion criteria were
that respondents should be > 18 years old and not
employed in the addiction treatment or the psychi-
atric services field. Participants were asked to verify
these criteria before continuing the online survey.
Data collection was anonymous, thus, ethical approval
and consent was deemed unnecessary according to
national regulations [23]. Nevertheless, replying to the
survey was considered as an implied consent.
Measures
The English SUSS version was translated to Norwegian
with a standard procedure (two forward and two back-
ward translations), in collaboration with the question-
naire’s lead developer (the third author of the present
paper) [24]. The SUSS consists of seven statements for
the disease model beliefs and five statements for the psy-
chosocial model beliefs subscales (Table 1), which were
found to cluster together in the only European psycho-
metric study of the instrument [15]. We did not use the
eclectic model subscale in this study, as recommended
[2, 15]. Respondents rated the statements on a 5-point
Likert scale ranging from the strongest disagreement
(score 0) to the strongest agreement (score 4) [8].
Statistical analyses
Demographics are presented with descriptive statistics,
as also were the observed mean and sum scores of
the SUSS subscales. We conducted a simultaneous
MGCFA according to standard procedure (the two
constructs under study were tested simultaneously)
[25, 26]. MGCFA is a special case of the structural
equation modeling approach and is based on the idea
that theoretical concepts are not directly observable,
but can be inferred from observed indicators (i.e.,
questions) that reflect the underlying construct (e.g.,
disease model beliefs) [27]. The analysis accounts for
both random and nonrandom measurement error
[28]. Analyzes were undertaken with the software pro-
gram Mplus, version 7.3, and we used the maximum
likelihood estimation with robust standard errors
(MLR) [29]. To handle missing values, the default
procedure in Mplus, full information maximum likeli-
hood was used.
First, baseline (configural) models for each group were
established. We understood and analyzed the questions as
reflective indicators of their respective construct, which
means that they are exchangeable; i.e., one can reduce the
number of items if necessary, without changing the con-
tent of the underlying latent variable [25]. Thus, to find
the most parsimonious model, problematic items were re-
moved if they did not work well in the analysis [e.g., had
low factor loadings (<0.4) or high error correlation with
other questions] [25, 30]. As global goodness of fit criteria
we used the Root Mean Square Error of Approximation
(RMSEA) (cut-off value for a good model fit < .06 and an
acceptable fit .06–.08), and the Comparative Fit Index
(CFI) (cut off value for a good model fit > .95 and an ac-
ceptable fit between .90 and .95) [31, 32].
Table 1 Short understanding of substance abuse scale (SUSS)a
Disease model beliefs
*Q1_D - Every alcoholic and addict must accept that he or she is
powerless over alcohol and drugs, and can never drink or use
drugs again
Q2_D - Every alcoholic or addict is one drink or one hit away from a
total relapse
Q5_D - Once a person is an alcoholic or an addict, he or she will
always be an alcoholic or an addict
*Q7_D - Usually if alcoholics and addicts fail to recover in AA / NA or
treatment, it is because they are unmotivated and in denial
Q8_D - If an alcoholic or addict is sober or straight for five years,
then starts drinking or using drugs again, he or she is right
back where he or she left off in the development of the
disease
Q11_D - There are only two possibilities for an alcoholic or drug
addict – permanent abstinence or death
Q12_D - If an alcoholic has a drink, or if an addict takes a hit, they lose
control and are unable to stop from getting drunk or high
Psychosocial model beliefs
Q3_P - The society or culture in which on grows up has a significant
influence on whether or not one becomes an alcoholic or an
addict
Q4_P - A person’s environment plays an important role in
determining whether he or she develops alcoholism or drug
addiction
*Q6_P - Alcoholism and drug addiction are caused, in part, by
growing up in a dysfunctional family
Q9_P - Alcoholism and drug addiction are caused, in part, by what
one learns about alcohol and drugs and the drinking/drug
use patterns of one’s family and peers
*Q10_P - A person can develop alcoholism or drug addiction because
of underlying psychological problems
Note:
aHumphreys K, Greenbaum MA, Noke JM, Finney JW: Reliability, validity, and
normative data for a short version of the Understanding of Alcoholism Scale.
Psychol Addict Behav 1996, 10(1):38–44
*Marked questions were excluded in the multigroup confirmatory factor
analysis and multiple indicator multiple cause model analysis due to the
development of the configural (baseline) model
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Proceeding to the multigroup analysis, the relations
between the latent variables and their respective indica-
tors across groups were compared [28]. To be able to
compare latent means, strong measurement invariance
(scalar equivalence) is needed [33]. Scalar equivalence
implies that the measurement scales do not only have
the same factor structure (i.e., configural equivalence)
and equal factor loadings (i.e., metric equivalence) across
groups, but also invariant intercepts, i.e., equivalent ori-
gin on the scales in the different groups [18]. We used
the new and simplified feature in Mplus 7 to test for in-
variance and included the syntax ‘MODEL = Configural
Metric Scalar’ in the ‘Analysis’ subsection. This proced-
ure implements cross-group equality constraints on
measurement parameters and compares more restricted
models with less restricted models (nested models) [29].
Chi-square difference tests between the nested models
are used in which the difference in chi-square value
(Δχ2) relative to the change in degrees of freedom (Δdf )
are evaluated, as are also the changes in CFI (ΔCFI) [29].
A non-significant Δχ2 value or a ΔCFI smaller than or
equal to −0.01 indicate that constraining the parameters
does not significantly worsen the fit of the model, and
the null hypothesis of measurement invariance can be
retained [34]. If our model showed not to be scalar in-
variant, intercepts of the non-invariant variables would
be freed to assume partial scalar equivalence, which is
still considered sufficient for comparing latent means if
at least two intercepts and loadings per construct are in-
variant [33]. Differences in latent means were examined
with the ‘professionals’ as the reference groups. The sig-
nificance level was set at p < 0.05.
In a next step we specified a multiple indicators mul-
tiple causes model (MIMIC) to control the latent mean
differences between the three groups for differences in
the distribution of age, gender and education between
the groups [35, 36]. For the specification and test of the
model, it was necessary to transform group membership
to dummy variables. The professional group was chosen
as a reference group. In addition to the two dummy vari-
ables representing patients and general public, age, edu-
cation and gender was added as covariates. The
regression coefficients of the dummy variables (groups)
can be interpreted as mean differences [36].
Results
The covariance coverage exceeded 98.8 % on all items,
which is excellent. Demographics and observed scorings
on the SUSS are shown in Table 2. In the following section
we refer to question numbers of the SUSS (Table 1). In
the psychosocial belief subscale, question 10 had a very
low loading (β = 0.16) and a non-significant R2 (0.02, p =
0.486) in the ‘patient’ sample. Similarly, question 6 had a
low loading (β = 0.34) and non-significant R2 (0.12, p =
0.06) in the general population sample. This implies no or
a very weak relationship between construct and indicator
[25]. Thus, these items were removed from the baseline
model and the multiple group analysis. We also chose to
remove two items in the disease belief subscale; question
7 because of low factor loadings in two of the groups
(∼0.4) and question 1 due to a high error correlation with
question 2 in the general public group. The modification
indices (MI) indicated that a chi-Square reduction of 24
(standardized parameter change) was expected if these re-
siduals were allowed to correlate. The high error correl-
ation can be explained by the very similar wording and
content of these two questions. After these adjustments of
the basic model, the baseline models for the different
groups had acceptable goodness-of-fit measures, and we
could use the same baseline model for each group (Fig. 1).
The multigroup analysis indicated that the model as a
whole was metric equivalent; the corrected Chi-square








Age (years) 45 (10) 41 (14) 43 (15)
Gender (female %) 72 34 62
Educational length (years) 15.6 (2.5) 11.2 (2.3) 14.2 (2.7)
Disease model belief; sum scoreb 15.8 (5.9) 21.4 (5.7) 16.9 (5.9)
Psychosocial model belief; sum scorec 13.0 (2.5) 13.2 (3.5) 12.0 (3.1)
Disease model belief; mean scored 2.2 (0.9) 3.0 (0.9) 2.3 (0.9)
Psychosocial model belief; mean scoree 2.6 (0.6) 2.6 (0.8) 2.4 (0.8)
Notes:
aVariables are shown as mean (SD)
bSum score of seven questions; 0–28 scale
cSum score of five questions; 0–20 scale
dMean of seven questions, score 0–4
eMean of five questions, score 0–4
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difference test between the configural and metric model
was non-significant (Δχ2/Δdf difference = 17/12, p =
0.17), and the ΔCFI was < −0.01 (Table 3). This means
that the factor loading between the groups did not differ
according to both criteria and the meaning of the
constructs can be compared over the three groups.
However, the model was not scalar equivalent as the
corrected difference test between the metric and the sca-
lar model was highly significant (Δχ2/Δdf = 66/12, p <
0.001), and the ΔCFI was > −0.01. As expected, the mul-
tigroup scalar model only had acceptable fit indices
(RMSEA = 0.08, CFI = 0.91); the MIs indicated that the
intercept of question 5 was non-invariant. When this
intercept was freed (i.e., a partial scalar model), the
model showed a good fit (RMSEA = 0.06, CFI = 0.95),
and the ΔCFI was −0.01 compared with the configural
model (Table 3). This implies that we reached full metric
invariance and partial scalar invariance, which is suffi-
cient for comparing latent means [19].
The differences in latent means between groups can
be seen in Table 4. The professionals served as the refer-
ence group. Compared to the professionals, the patients
Fig. 1 Baseline model for the multigroup confirmatory factor analysis of the Short Understanding of Substance Abuse Scale (SUSS) in the three studied
groups: professionals, patients and general public, N = 640 participants. Notes: − DIS = disease model beliefs - PSY = psychosocial model beliefs - Q2_d,
Q5_d, Q8_d, Q11_d, Q12_d = indicators for the disease model beliefs, see Table 1 for question wording - Q3_p, Q4_p, Q9_p = indicators for the
psychosocial model beliefs, see Table 1 for question wording
Table 3 Multigroup confirmatory factor analysis results of the
measurement invariance tests across the three groups
(professionals, patients and general public, N = 640)
χ2 df RMSEAa CFIb
Configural model 104 57 0.06 0.96
Metric model 121 69 0.06 0.96
Scalar model 187 81 0.08 0.91
Partial scalar model 143 79 0.06 0.95
Notes:
aRMSEA = Root Mean Square Error of Approximation
bCFI = Comparative Fit Index
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had a significantly ∼ 1 point higher mean score on the
disease model belief scale. The psychosocial belief score
was not significantly different. The general population
group also had a significantly higher disease model belief
score compare to the reference group. However, the
nominal distance was much smaller with a 0.25 point
higher mean score. The psychosocial belief score was
significantly lower than the professionals, but again, the
nominal difference was not large; 0.19.
Effect sizes are not directly computed in Mplus. In
order to examine the magnitude of the difference in the
latent mean scores, we calculated an effect size d for the
latent mean differences following the procedure pro-
posed by Hancock [37]. The effect size d for the patients
versus the professionals was 1.15 for disease model be-
liefs and 0.23 for psychosocial model beliefs. For the
general public group versus the professionals, the effect
size d was 0.28 for disease model beliefs and 0.33 for
psychosocial model beliefs. According to interpretative
guidelines; 0.2, 0.5 and 0.8 are cut-off values for a small,
medium and large effect size of latent means, this
indicates a large effect size of patients versus the profes-
sionals on disease model beliefs and a small sized effect
on the other differences between groups [37].
Figure 2 shows the path diagram for the proposed
MIMIC model tested with MPLUS. As the intercept of
question 5 was freely estimated across groups in the
MGCFA model, we allowed direct relationship between
the dummy variables representing the groups and the
item question 5. This relationship, termed differential
item bias, reflects the fact that group membership has a
direct effect on question 5 and not all the effect is medi-
ated by the latent construct itself. Table 5 reports the es-
timates of latent mean difference obtained from the
Table 4 Differences in latent means between groups on the Short Understanding of Substance Abuse Scale (SUSS) for N = 640
participantsa
Professionalsb Patients General public
Disease model beliefs 0.00 1.02 (0.10), p < 0.001 0.25 (0.09), p = 0.006
Psychosocial model beliefs 0.00 0.13 (0.09), p = 0.131 −0.19 (0.07), p = 0.006
Notes:
aLatent means are obtained from a Multigroup confirmatory factor analysis with cross-groups partial scalar invariance. The brackets show standard errors
bReference group
Fig. 2 Multiple indicator multiple cause model of the Short Understanding of Substance Abuse Scale (SUSS), N = 640 participants. Notes: − DIS =
disease model beliefs - PSY = psychosocial model beliefs - Education = length of education (years) - Q2_d, Q5_d, Q8_d, Q11_d, Q12_d = indicators
for the disease model beliefs, see Table 1 for question wording - Q3_p, Q4_p, Q9_p = indicators for the psychosocial model beliefs, see Table 1
for question wording
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MIMIC model when controlled for gender, age and edu-
cational level. Compared to the results from the MGCFA
model in Table 4, the estimated latent mean differences
for psychosocial model beliefs changed only slightly and
attained significance. However, the differences for the
disease model beliefs reduced in size and the difference
between the professionals and the general public group
turned non-significant.
The two constructs, disease and psychosocial model
beliefs, were uncorrelated (r = −.01, p = 0.76). The two
scales thus tap distinct and unrelated constructs.
Discussion
This examination of the SUSS yielded a partial scalar in-
variant model. Hence, we were able to compare latent
means between groups. In unadjusted comparisons, pa-
tients and the general public reported significantly
higher endorsement of disease model beliefs than did
professionals. The effect size of the difference between
professionals and patients was large and persisted after
controlling for possible confounders. In both unadjusted
and adjusted analyses, the general public group but not
the patient group scored lower than professionals on the
psychosocial belief scale.
The findings in the present study indicate that the pro-
fessionals were “out of step” with their patients as well
as with the general public especially regarding their lim-
ited endorsement of the disease model. Prior SUSS stud-
ies have shown that this same pattern of beliefs hold in
the U.S. for psychologists, but not for other addiction
treatment professionals [8]. Both psychosocial and dis-
ease model belief systems can be said to have some sup-
port in the research literature in that interventions
informed by each are comparably effective (e.g., 12-step
facilitation counseling and CBT) [38]. Whether the pa-
tients or the professionals should change their beliefs in
order to come to a shared view of SUD is a philosophical
question as much as an empirical one, which observers
will answer differently depending on whether they think
health care professionals or those with experiential
knowledge should be able to define illnesses [39].
In any event, what are the consequences of the differ-
ent views in the communication between professionals
and patients? If professionals are not aware of or do not
appreciate such common understandings of addiction,
their patients may feel misunderstood or alienated and
drop out of care. The orientation of the professional
should not be to prove that they are right and the client
is wrong, but to accept that there are multiple useful
ways to understand the experience of addiction. One of
the important new trends in the health services in gen-
eral is the focus on patient-centered care [40]. The over-
all idea is to promote active patient involvement in
which patient and clinician communicate their expecta-
tions and preferences for treatment, and jointly agree
upon the treatment to be implemented [41]. Differences
in beliefs may be a challenge in achieving this in Norwe-
gian addiction treatment. The likelihood of treatment
goals being realized is generally assumed to be higher
when patients and clinicians agree on them, and the pro-
fessionals are responsible for establishing a common
ground [42]. Being patient-centered may require clini-
cians be accepting of patients’ disease model beliefs even
when the professionals do not share them.
As for the comparison between the professionals and
the general public, the difference was in the expected
direction when it came to the psychosocial model. Edu-
cation often exposes the professional to learning theory,
which would translate into greater endorsement of a
psychosocial understanding of substance misuse [43].
Maybe for similar reasons, lay respondents had a higher
support for the disease perspective than professionals,
although the difference was not as large as that between
the patients and the professionals. It may be tempting to
dismiss the public’s views as a product of ignorance of
the realities of addiction, but the view of the lay respon-
dents concerning the disease model beliefs tended to
draw in the same direction as those experiencing the
disorder. It is possible that professional training in
Norway actively “trains out” professionals from the most
widespread understandings of addiction, whereas in
other countries professional education more closely
maps it. This is not in an absolute sense good or bad, ex-
cept to the extent that misunderstandings and miscom-
munication between the public and professionals may
lower support for treatment. However, we perceive that
there is a strong support for SUD treatment initiatives
and also support to pay taxes for it in the Norwegian so-
ciety [44]. One might speculate that the prevalent en-
dorsement of the disease model of SUD among the
Table 5 Differences in latent means between groups on the Short Understanding of Substance Abuse Scale (SUSS) controlling for
age, gender and educationa
Professionalsb Patients General public
Disease model beliefs 0.00 0.67 (0.13), p < 0.001 0.13 (0.09), p = 0.156
Psychosocial model beliefs 0.00 0.19 (0.11), p = 0.07 −0.17 (0.07), p = 0.019
Notes:
aDifferences in latent means are obtained from a multiple indicator multiple cause (MIMIC) model. The brackets show standard errors
bReference group
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public actually paves the way for this support by legitim-
izing treatment as a medical activity.
The finding that the two constructs were uncorrelated
means that a high endorsement of disease model beliefs
does not exclude a high endorsement of psychosocial
model beliefs and vice versa. Despite the emphasis that
is sometimes placed on the alleged conflict between 12-
step beliefs and psychosocial learning approaches [14],
in reality many people integrate them smoothly. When
examining the questions of the disease model beliefs,
one can see that they are concerned with the need for
continued abstinence, and as such, pertain to depend-
ence as a chronic condition. The psychosocial model be-
lief questions bear upon the development of the
condition. Our findings indicate that strong endorse-
ment of disease model beliefs does not necessarily mean
that psychosocial factors that may have contributed to
the condition are unrecognized. Conversely, when
people have a high focus on the development of the con-
dition and have high scorings on the psychosocial model
belief scale, they may still recognize abstinence as a vital
treatment goal [14].
As a direct comparison of these three groups has never
been undertaken before, it is difficult to put our finding
into an international perspective. One possible way to do
it, would be to compare the sum scores of all the SUSS
questions (see Table 1) with previous studies among pro-
fessionals. The disease model belief scale was in the
present study somewhere in-between previous findings
from Switzerland and the U.S. The Norwegian profes-
sionals scored a mean of 15.8 (scale 0–28), whereas
previous research showed that Swiss professionals scored
8.4 and U.S. professionals scored 18.5 [8, 15]. Norway is
not at all dominated by the classic AA-influenced disease
model in its addiction treatment services; less than 5 % of
the addiction treatment centers employ a 12-step based
treatment model [16]. Thus, it is unexpected that
Norwegian professionals seemed to endorse disease model
beliefs more than do Swiss personnel. This finding may re-
flect that Norwegian professionals still consider abstinence
as the main treatment goal for patients with dependence,
although a previous study found that the acceptance of
non-abstinence as a treatment goal was widespread [45].
That study assessed agency policies and practices, though,
and did not assess the attitudes of individual providers.
Concerning the psychosocial model beliefs, the scores
were quite similar among the countries (Swiss = 12.3,
Norway = 13.0 and the U.S. = 13.2). We have not been able
to find normative data from studies among patients.
Methodological considerations
How generalizable are these results to Norway as a
whole? Although slightly older (41 versus 38 years), the
patient sample was similar to the detox patients (N =
564) of a previous regional multisite study [46]; they ex-
hibited similar gender, ethnicity, major substance of
abuse, and previous SUD treatment [21]. We have no
reason to believe that the professionals of the surveyed
health region differ from other regions in Norway. Thus,
the findings of the present study were generalizable to
other detox patients in the region and addiction profes-
sionals in Norway at large. However, as the patients were
in-patients on a detoxification unit, the findings may not
be generalized to patients with less severe SUDs. The
general public survey was undertaken years later than in
the other groups. We are not aware of any large-scaled
public debates or changes in policy that may have con-
tributed to temporal changes in the public opinion dur-
ing this period. One could expect that the Facebook
recruitment would bias the results by appealing more to
younger, technology-saavy individuals, but this was not
apparent in the data; the mean age was quite similar
across groups. The general public sample was a conveni-
ence sample, and thus, the representativeness of this
sample to the population at large is uncertain. Friend-
ship with an author could possibly influence a partici-
pant’s beliefs by those of the author [47]. To avoid this
social contagion bias as much as possible, the link to the
online survey was not placed directly on the first au-
thor’s Facebook account; rather it was posted on differ-
ent Facebook groups or sent to contacts of friends of the
first author. Further, those of the author’s social contacts
who work in the addiction or psychiatry fields could not
have participated. However, as this data collection was
anonymous, we cannot rule out that there may have
been some overlap with the first author’s friends. The
first application of a validated scale in a new country
and the first ever examination of beliefs in the general
population remain strengths of the study.
Future research
Based on the existing questions in the SUSS, there is
sparse information in the disease model construct on
how the illness develops. Conversely, there is no in-
formation in the psychosocial model construct on
how to cope with the illness. Thus, it would be inter-
esting to expand this type of research and combine it
with the model of helping and coping suggested by
Brickman et al. [48]. These authors emphasize the ne-
cessity of distinguishing between attribution of re-
sponsibility for a problem (who is to blame), and
attribution of responsibility for a solution to the
problem (who is in control of the needed action to
solve it), yielding a more differentiated framework.
For example, the disease model construct is differenti-
ated into two categories; the typical medical model,
where neither the illness nor the treatment is the per-
son’s responsibility, whereas in the compensatory
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model, people are not blamed for their problems, but
are still held responsible for and expected to be ac-
tively involved in solving these problems. The latter is
popularly articulated in the words of Jesse Jackson;
“You are not responsible for being down, but you are
responsible for getting up!” This is in line with the
philosophy of the AA program, in which the individ-
ual is not blamed for having the disease, but is cer-
tainly held responsible for taking action steps to
maintaining remission [49, 50]. Brickman et al. state
that a wrong choice of model may undermine both
an effective helping and a coping strategy. A combin-
ation of the SUSS and Brickman et als’ models would
allow an examination of the conception of addiction
in a more differentiated framework.
Conclusions
As was found in the Swiss study, the disease and psy-
chosocial model subscales of the SUSS worked well in
a Norwegian sample after some amendments to the
constituent items. This suggests both that the SUSS
has broad cultural application but at the same time
should be tested and validated in each culture or sub-
culture in which it is employed. More cross-cultural
tests of the scale – which is available free of charge
to researchers and clinicians – would be highly
desirable.
Substantively, the study found that addiction treatment
professionals have different understandings of substance
use disorder than patients and the general public. Care
must be taken that this does not result in miscommuni-
cation or poor relationships that could compromise the
quality of the therapeutic alliance.
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